Evaluation of pregnancy outcomes in IVF cycles with uterine support with progesterone, Prolotex, and Cyclogest in the infertility center.

Phase 4

Recruiting

• Conditions: N97.9; Types of female infertility.; Female infertility, unspecified

• Registration Number: IRCT20141217020351N12
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 309

Inclusion Criteria

Infertile women aged 18 to 42 years
BMI less than 30
Having less than three IVF cycles
FSH < 15 U/L
Estradiol less than 80 pg / ml
Having a normal uterine cavity on a recent hysteroscopy, sonohistogram, or hysterosalpingogram

Exclusion Criteria

Intramural fibroids deforming the uterine cavity
Endometriosis stage three and four
Hydrosalpinx
History of poor response to treatment
Spontaneous abortion
Adrenal disease
Thyroid disease
Thromboembolic diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical Pregnancy. Timepoint: Ten weeks after starting treatment. Method of measurement: Blood tests and ultrasound.

Secondary Outcome Measures

Name	Time	Method
Abortion. Timepoint: 10 weeks after embryo transfer. Method of measurement: Blood tests and ultrasound.;Ectopic Pregnancy. Timepoint: 5 weeks after embryo transfer. Method of measurement: Blood tests and ultrasound.